Artrya Ltd (ASX:AYA) CEO John Barrington joins Proactive to discuss regulatory approval for its Salix Coronary Anatomy product in Europe. The European Notified Body gave the green light for Artrya to begin marketing Salix in 28 European Economic Area member countries, opening a large new market opportunity for the company.
Artrya gains access to 28 European markets with Salix Coronary Anatomy product
